as of 12-03-2025 11:15am EST
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
| Founded: | 2002 | Country: | Switzerland |
| Employees: | 2 | City: | N/A |
| Market Cap: | 11.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 8.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.51 - $12.05 | Next Earning Date: | 12-04-2025 |
| Revenue: | $198,824 | Revenue Growth: | -71.81% |
| Revenue Growth (this year): | 86.57% | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
See how ADXN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "ADXN Addex Therapeutics Ltd - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.